Rare Diseases: What Makes China A Rising Star?

Top corporate executives are increasingly turning their attention to rare diseases in China as changing regulatory policies provide a rare opening, and aided by more physicians advocating for orphan drug access. What does the first ever report on rare diseases in China have to say about the opportunities and challenges?

China Rare Disease Report 2018 • Source: Pink Sheet

Despite being the most populous nation in the world, China has not focused on rare diseases until recently. But fueled by encouraging regulatory policy changes, the speed of the effort to catch up with the rest of the world has been rapid. Two top medical experts recently published the country's first-ever report devoted to rare diseases, which paints the big picture for the diagnosis and treatment of these conditions in the country.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Asia